- Associated Press•13 hours ago
On a per-share basis, the Dublin 4, Ireland-based company said it had a loss of 31 cents. Losses, adjusted for stock option expense and non-recurring costs, were 1 cent per share. The results surpassed ...
- Insider Monkey•yesterday
Recro Pharma Inc (NASDAQ:REPH) is up more than 27% on Wednesday after announcing data from its lead acute pain trial. The company has developed an IV formulation of an already established drug, and is currently enrolling in the second of two pivotals that will form the basis of a New Drug Application if all runs smoothly. […]
After hours: 48.130.00 (0.00%) as of 4:56 PM EDT
|Bid||48.20 x 100|
|52wk Range||27.14 - 80.71|
|Day's Range||47.23 - 51.50|
|Avg Vol (3m)||976,155|
As of 4:00 PM EDT. Market closed.